As Crohn’s disease falls under the umbrella of inflammatory bowel disease, the prevalence is murky, but estimates suggest it may affect 1 million Americans.
The calprotectin biomarker test stands at the crossroads to help direct physicians and patients to appropriate focused care for gut and brain symptoms.
As Crohn’s disease falls under the umbrella of inflammatory bowel disease, the prevalence is murky, but estimates suggest it may affect 1 million Americans.
The calprotectin biomarker test stands at the crossroads to help direct physicians and patients to appropriate focused care for gut and brain symptoms.